Ingeborg Hilderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ingeborg Hilderson has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Hannelore Denys
Department of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium
2 shared publications - Katrien Vandecasteele
Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium
2 shared publications - Aglaja De Pauw
Medical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium
1 shared publication - An Hendrix
Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium
1 shared publication - Celine Jacobs
Department of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium
1 shared publication - Eline Naert
Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium
1 shared publication
Latest Publications
- Open Access
Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study
Purpose: This longitudinal survey study aimed to investigate the self-reported outcome measures of COVID-19 peritraumatic distress, depression, anxiety, stress, quality of life (QOL), and their associated factors in a cohort of cancer patients treated at a tertiary care hospital during the SARS-CoV-2 pandemic. Methods: Surveys were administered at four time points between 1 April 2020 and 18 September 2020. The surveys included the CPDI, DASS-21, and WHOQOL-BREF questionnaires. Results: Survey response rates were high (61.0% to 79.1%). Among the 355 participants, 71.3% were female, and the median age was 62.2 years (IQR, 53.9 to 69.1). The majority (78.6%) were treated with palliative intention. An important proportion of the participants reported symptoms of COVID-19 peritraumatic distress (34.2% to 39.6%), depression (27.6% to 33.5%), anxiety (24.9% to 32.7%), and stress (11.4% to 15.7%) at any time point during the study period. We did not find clinically meaningful mental health and QOL differences during the study period, with remarkably little change in between the pandemic’s first and second wave. We found no consistent correlates of mental health or QOL scores, including cancer type, therapy intention, and sociodemographic information. Conclusion: This cohort of cancer patients showed considerable resilience against mental health and QOL deterioration during the SARS-CoV-2 pandemic.
Open AccessMental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study
Purpose: This longitudinal survey study aimed to investigate the self-reported outcome measures of COVID-19 peritraumatic distress, depression, anxiety, stress, quality of life (QOL), and their associated factors in a cohort of cancer patients treated at a tertiary care hospital during the SARS-CoV-2 pandemic. Methods: Surveys were administered at four time points between 1 April 2020 and 18 September 2020. The surveys included the CPDI, DASS-21, and WHOQOL-BREF questionnaires. Results: Survey response rates were high (61.0% to 79.1%). Among the 355 participants, 71.3% were female, and the median age was 62.2 years (IQR, 53.9 to 69.1). The majority (78.6%) were treated with palliative intention. An important proportion of the participants reported symptoms of COVID-19 peritraumatic distress (34.2% to 39.6%), depression (27.6% to 33.5%), anxiety (24.9% to 32.7%), and stress (11.4% to 15.7%) at any time point during the study period. We did not find clinically meaningful mental health and QOL differences during the study period, with remarkably little change in between the pandemic’s first and second wave. We found no consistent correlates of mental health or QOL scores, including cancer type, therapy intention, and sociodemographic information. Conclusion: This cohort of cancer patients showed considerable resilience against mental health and QOL deterioration during the SARS-CoV-2 pandemic.
- Open Access
- 20 January 2022
- Published by Elsevier in The Breast
- Vol. 62, 10-15
Safety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial
- 20 January 2022
- Published by Elsevier in The Breast
- Vol. 62, 10-15
Open AccessSafety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial